Our studies not only provide solid preclinical testing of exogenous CO in models of lung cancer but also indicate that MAPK-Erk1/2→Notch1 signaling dominates in the tumor microenvironment upon treatment with exogenous CO and might be critical for suppression of tumor growth (Supplementary Figure S7). Here, MAPK3 is linked to neoplasm.